Aug 24 (Reuters) - The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union.

The EU on Friday authorised the sale of a vaccine to protect infants from respiratory syncytial virus (RSV), a disease that in worst cases can lead to pneumonia and bronchiolitis. The bloc-wide ...

If the CDC recommends the vaccine, named Abrysvo, it will be the first vaccine available to protect newborns against RSV, ...

The advisory committee on immunizations for the Centers for DIsease Control and Prevention (CDC) voted to recommend an RSV ...

The Centers for Disease Control and Prevention recommended on Friday the first maternal RSV vaccine for pregnant people given ...

The Centers for Disease Control and Prevention’s independent vaccine advisers voted to recommend a maternal vaccine that ...

The U.S. Food and Drug Administration on Monday approved the first vaccine that protects newborns from respiratory syncytial virus, known as RSV. The vaccine, made by Pfizer, is given to mothers ...

Aug 24 (Reuters) - The European Commission on Thursday approved U.S. drugmaker Pfizer's (PFE.N) vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the ...

(Reuters) -The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union. The ...

Aug 24 (Reuters) - The European Commission on Thursday approved U.S. drugmaker Pfizer's PFE.N vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European ...

(Reuters) -The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union.